Effect of spironolactone on the expression of rat hepatic UDP-glucuronosyltransferase

Biochemical Pharmacology

Volumn 66, Issue 1, 2003, Pages 171-177

  Catania, Viviana A ^a   Luquita, Marcelo G ^a   Sánchez Pozzi, Enrique J ^a   Ikushiro, Shin Ichi ^b   Emi, Yoshikazu ^b   Iyanagi, Takashi ^b   Mottino, Aldo D ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSITY OF HYOGO   (Japan)

Author keywords

Bilirubin; Ethynylestradiol; p Nitrophenol; Rat liver; Spironolactone; UDP glucuronosyltransferase

Indexed keywords

4 NITROPHENOL; ALAMETHICIN; BILIRUBIN; ETHINYLESTRADIOL; GLUCURONOSYLTRANSFERASE; ISOENZYME; LIPID; MESSENGER RNA; PHENOL DERIVATIVE; SPIRONOLACTONE; STEROID; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG EFFECT; DRUG GLUCURONIDATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; LATENT PERIOD; LIPID COMPOSITION; LIVER; LIVER MICROSOME; MALE; MICROSOME MEMBRANE; MOLECULAR BIOLOGY; NONHUMAN; NORTHERN BLOTTING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; RAT; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 0038343614     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00232-6     Document Type: Article

References (53)

1. Tephly T.R., Burchell B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol. Sci. 11:1990;276-279.
2. Burchell B., Nebert D.W., Nelson D.R., Bock K.W., Iyanagi T., Jansen P.L.M., Lancet D., Mulder G.J., Roy Chowdhury J., Siest G., Tephly T.R., Mackenzie P. The UDP-glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 10:1991;487-494.
3. Emi Y., Ikushiro S., Iyanagi T. Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J. Biochem. (Tokyo). 117:1995;392-399.
4. Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T., Owens I.S. A novel complex locus UGT1 encodes human bilirubin phenol and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem. 267:1992;3257-3261.
5. Sato H., Koiwai O., Tanabe K., Kashiwamata S. Isolation and sequencing of rat liver bilirubin UDP-glucuronosyltransferase sDNA: possible alternate splicing of a common primary transcript. Biochem. Biophys. Res. Commun. 169:1990;260-264.
6. Pritchard M., Fournel-Gigleux S., Siest G., Mackenzie P., Magdalou J. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol. Pharmacol. 45:1994;42-50.
7. Green M.D., Oturu E.M., Tephly T.R. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab. Dispos. 22:1994;799-805.
8. Miners J.O., Mackenzie P.I. Drug glucuronidation in humans. Pharmacol. Ther. 51:1991;347-369.
9. Burchell B, Coughtrie MW, Jansen PL. Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease. In: Report of the Seventh International Workshop on Glucuronidation, September 1993; Pitlochry, Scotland. Hepatology 1994;20:1622-30.
10. Zakim D., Dannenberg A.J. How does the microsomal membrane regulate UDP-glucuronosyltransferases? Biochem. Pharmacol. 43:1992;1385-1393.
11. Berg C.L., Radomiska A., Lester R., Gollan J.L. Membrane translocation and regulation of uridine diphosphate-glucuronic acid uptake in rat liver microsomal vesicles. Gastroenterology. 108:1995;183-192.
12. Bossuyt X., Blanckaert N. Mechanism of stimulation of microsomal UDP-glucuronosyltransferase by UDP-N-acetylglucosamine. Biochem. J. 305:1995;321-328.
13. Peters W.H., Jansen P.L., Nauta H. The molecular weights of UDP-glucuronyltransferase determined with radiation inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase. J. Biol. Chem. 259:1984;11701-11705.
14. Ikushiro S., Emi Y., Iyanagi T. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry. 36:1997;7154-7161.
15. Meech R., Mackenzie P. UDP-glucuronosyltransferase, the role of the amino terminus in dimerization. J. Biol. Chem. 272:1997;26913-26917.
16. Burchell B., Coughtrie M.W.H. UDP-glucuronyltransferases. Pharmacol. Ther. 43:1989;261-289.
17. Mackenzie P.I., Gonzalez F.J., Owens I.S. Cell free translation of mouse liver mRNA coding for two forms of UDP glucuronosyltransferase. Arch. Biochem. Biophys. 230:1984;676-680.
18. Ikushiro S., Emi Y., Iyanagi T. Identification and analysis of drug-responsive expression of UDP-glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes using anti-peptides antibodies. Arch. Biochem. Biophys. 324:1995;267-272.
19. Ochs H.R., Greenblat D.J., Bodem G., Smith T.W. Spironolactone. Am. Heart J. 96:1978;389-400.
20. Solymoss B., Zigmond G. Effect of various steroids on the hepatic glucuronidation and biliary excretion of bilirubin. Can. J. Physiol. Pharmacol. 51:1973;319-323.
21. Mottino A.D., Rassero J.A., Rodríguez Garay E.A. Effect of spironolactone on bilirubin conjugation by the rat liver. Biochem. Pharmacol. 28:1979;2215-2217.
22. Catania V.A., Luquita M.G., Carrillo M.C., Mottino A.D. Sex differences in spironolactone induction of rat intestinal and hepatic p-nitrophenol UDP-glucuronyltransferase. Can. J. Physiol. Pharmacol. 68:1990;1385-1387.
23. Miguet J.P., Vuitton D., Thebault-Lucas A., Joanne C., Dhumeaux D. Spironolactone and enzyme induction in patients with alcoholic cirrhosis. Gastroenterology. 78:1980;996-1000.
24. +)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat. Hepatology. 3:1983;481-488.
25. Mottino A.D., Guibert E.E., Rodríguez Garay E.A. Additive effect of combined spironolactone and phenobarbital treatment on hepatic bilirubin UDP-glucuronyltransferase. Biochem. Pharmacol. 38:1989;851-853.
26. Siekevitz P. Preparation of microsomes and submicrosomal fractions. Methods Enzymol. 5:1962;61-68.
27. Gornall A.G., Bardawill E.J., David M.M. Determination of serum proteins by means of the biuret reactions. J. Biol. Chem. 177:1949;751-766.
28. Sánchez Pozzi E.J., Luquita M.G., Catania V.A., Rodríguez Garay E.A., Mottino A.D. Inhibition of rat liver microsomal bilirubin UDP-glucuronosyltransferase by ursodeoxycholic acid. Life Sci. 55:1994;111-120.
29. Sánchez Pozzi E.J., Catania V.A., Rodríguez Garay E.A., Mottino A.D. Enhancement of intestinal bilirubin UDP-glucuronosyltransferase activity by modification of microsomal lipid composition. Biochim. Biophys. Acta. 1245:1995;293-298.
30. Catania V.A., Dannenberg A.J., Luquita M.G., Sánchez Pozzi E.J., Tucker J.K., Yang E.K., Mottino A.D. Gender-related differences in the amount and functional state of rat liver UDP-glucuronosyltransferase. Biochem. Pharmacol. 50:1995;509-514.
31. Luquita M.G., Catania V.A., Sánchez Pozzi E.J., Veggi L.M., Hoffman T., Pellegrino J.M., Ikushiro S., Emi Y., Iyanagi T., Vore M., Mottino A.D. Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. J. Pharmacol. Exp. Ther. 298:2001;49-56.
32. Ebner T., Remmel R.P., Burchell B. Human bilirubin UDP-glucuronyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol. Pharmacol. 43:1993;649-654.
33. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Roy Chowdhury J., Ritter J.K., Schachter H., Tephly T.R., Tipton K.E., Nebert D.W. The UDP-glucosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7:1997;255-269.
34. Ojcius D.M., Young J.D. Cytolytic pore-forming proteins and peptides: is there a common structural motif? Trends Biochem. Sci. 16:1991;225-229.
35. Voice M.W., Burchell A. The effect of the pore forming antibiotic, alamethicin, on the hepatic microsomal glucose-6-phosphatase system. Biochem. Soc. Trans. 20:1992;38S.
36. Fulceri R., Bánhegyi G., Gamberucci A., Giunti R., Mandl J., Benedetti A. Evidence for the intraluminal positioning of p-nitrophenol UDP-glucuronosyltransferase activity in rat liver microsomal vesicles. Arch. Biochem. Biophys. 309:1994;43-46.
37. Little J.M., Lehman P.A., Nowell S., Samokyszyn V., Radominska A. Glucuronidation of all-trans-retinoic acid and 5,6-epoxy-all-trans-retinoic acid. Activation of rat liver microsomal UDP-glucuronosyltransferase activity by alamethicin. Drug Metab. Dispos. 25:1997;5-11.
38. Fisher M.B., Campanale K., Ackermann B.L., Vandenbranden M., Wrighton S.A. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab. Dispos. 28:2000;560-566.
39. Mackenzie P.I. Rat liver UDP-glucuronosyltransferase. Sequence and expression of a cDNA encoding a phenobarbital-inducible form. J. Biol. Chem. 261:1986;6119-6125.
40. Barbu V., Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res. 17:1989;7115-7117.
41. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
42. Luquita M.G., Sánchez Pozzi E.J., Catania V.A., Mottino A.D. Analysis of p-nitrophenol glucuronidation in hepatic microsomes from lactating rats. Biochem. Pharmacol. 47:1994;1179-1185.
43. Bánhegyi G., Braun L., Marcolongo P., Csala M., Fulceri R., Mandl J., Benedetti A. Evidence for an UDP-glucuronic acid/phenol glucuronide antiport in rat liver microsomal vesicles. Biochem. J. 315:1996;171-176.
44. Van Steenbergen W., Fevery J. Effects of uridine-diphosphate glucuronosyltransferase activity on the maximal secretion rate of bilirubin conjugates in the rat. Gastroenterology. 99:1990;488-499.
45. Mottino A.D., Guibert E.E., Carnovale C.E., Morisoli L.S., Rodríguez Garay E.A. Formation of bilirubin monoglucuronide and diglucuronide in isolated rat hepatocytes. Effect of spironolactone. Biochem. Pharmacol. 32:1983;3157-3161.
46. Wirth K.E., Frölich C.J., Hollifield J.W., Falkner F.C., Sweetman B.S., Oates J.A. Metabolism of digitoxin in man and its modification by spironolactone. Eur. J. Clin. Pharmacol. 9:1976;345-354.
47. Schmoldt A., Promies J. On the substrate specificity of the digitoxigenin monodigitoxoside conjugating UDP-glucuronyltransferase in rat liver. Biochem. Pharmacol. 31:1982;2285-2289.
48. Chen K.K., Henderson F.G. Pharmacology of sixty-four cardiac glycosides and aglycones. J. Pharmacol. Exp. Ther. 111:1954;365-383.
49. von Meyerinck L., Coffman B.L., Green M.D., Kirkpatrick R.B., Schmoldt A., Tephly T.R. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity. Drug Metab. Dispos. 13:1985;700-704.
50. Hazelton G.A., Klaassen C.D. UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside. Differences in activation and induction properties in rat and mouse liver. Drug Metab. Dispos. 16:1988;30-36.
51. Iyanagi T. Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J. Biol. Chem. 266:1991;24048-24052.
52. Schmoldt A., Blomer I., Johannes A. Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man. Naunyn Schmiedebergs Arch. Pharmacol. 346:1992;226-233.
53. Lacarelle B., Rajaonarison J.F., Catalin J., Durand A., Cano J.P. UDP-glucuronosyltransferase activity toward digitoxigenin monodigitoxoside in human liver microsomes. Drug Metab. Dispos. 21:1993;338-341.